Duopharma Biotech Bhd 's corporate office
PETALING JAYA: Amid the challenging economic conditions compounded by the Covid-19 outbreak, Duopharma Biotech Bhd
expects its revenue for this year to be spurred by the expansion of its product range.
The associate of Permodalan Nasional Bhd (PNB) and one of the leading players in the pharmaceutical space said it is also on track to achieve its production target this year.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
